Paulson & Co 13F, Q2 2023

John Paulson · quarter ending 30 June 2023 · filed 14 August 2023 · SEC CIK 1035674

$1.02B
Filed US book
21
Positions
20.6%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q2 2023

Weights are against the whole filed book.

CompanyTickerValue% of book
BAUSCH HEALTH COS INCBHC$211.51M20.6%
BRIGHTSPHERE INVT GROUP INCAAMI$187.51M18.3%
PERPETUA RESOURCES CORPPPTA$90.91M8.9%
NOVAGOLD RES INCNG$88.68M8.7%
MADRIGAL PHARMACEUTICALS INCMDGL$80.90M7.9%
ANGLOGOLD ASHANTI LIMITED$80.85M7.9%
HORIZON THERAPEUTICS PUB L$51.42M5.0%
THRYV HLDGS INCTHRY$49.20M4.8%
AGNICO EAGLE MINES LTDAEM$39.16M3.8%
SSR MINING INSSRM$28.36M2.8%
INTERNATIONAL TOWER HILL MINTHM$25.71M2.5%
SEABRIDGE GOLD INCSEA1EUR$24.94M2.4%
NEWMONT CORPNEM$19.28M1.9%
EQUINOX GOLD CORPEQX$11.45M1.1%
TRILOGY METALS INC NEWTMQ$8.50M0.8%
NEWMARK GROUP INCNMRK$7.99M0.8%
TELLURIAN INC NEW$7.53M0.7%
IAMGOLD CORPIAG$4.87M0.5%
ALIBABA GROUP HLDG LTDBABA$4.17M0.4%
IVERIC BIO INC$983.5K0.1%
DIVERSEY HLDGS LTD$419.5K0.0%

This is the earliest Paulson & Co 13F we hold, so there is no earlier filing here to compare it with.

Other quarters

Source: SEC Form 13F-HR, accession 0001013594-23-000696, filed by PAULSON & CO. INC.. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.